Literature DB >> 15939106

An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension.

Yu-Jing Fang1, G Neil Thomas, Zong-Li Xu, Ji-Qian Fang, Julian A J H Critchley, Brian Tomlinson.   

Abstract

BACKGROUND: Dopamine modulates a variety of physiological functions including natriuresis and satiety. We have previously reported that the TaqI polymorphism of the dopamine D2 receptor (DD2R) gene is associated with both blood pressure and obesity indices in a normoglycaemic Hong Kong Chinese population. In this study, we present evidence confirming the linkage between this gene polymorphism, obesity and hypertension.
METHODS: Two hundred and seventy-four siblings from 96 normoglycaemic hypertensive families were recruited, including 133 who were hypertensive. Central obesity was defined as a waist-to-hip ratio of > or = 0.9 and > or = 0.85 in males and females, respectively, and was identified in 99 of the siblings. The DD2R gene TaqI polymorphism was identified with a polymerase chain reaction based restriction fragment length polymorphism protocol. The affected pedigree member (APM) linkage analysis (sib-pair program, version 0.99.9, by D.L. Duffy) was used to assess for linkage between this gene polymorphism, obesity and hypertension in 73 families with siblings discordant for hypertension.
RESULTS: The A1 allele frequencies were similar in the 133 hypertensive, and 141 normotensive siblings, including the 99 centrally obese siblings at 0.431, 0.421 and 0.418, respectively. APM linkage analysis suggested that the DD2R gene TaqI polymorphism had evidence of linkage with blood pressure (T = -1.86, P = 0.013), as well as with obesity (T = -1.58, P = 0.007).
CONCLUSION: Our data in normoglycaemic Hong Kong Chinese supports that the DD2R gene TaqI polymorphism is a marker associated with the pathogenesis of obesity and hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939106     DOI: 10.1016/j.ijcard.2004.05.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese.

Authors:  Yu-Jing Fang; Han-Bing Deng; G Neil Thomas; Chi H Tzang; Cai-Xia Li; Zong-Li Xu; Mengsu Yang; Brian Tomlinson
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

Review 2.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 3.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Authors:  Ines Armando; Prasad Konkalmatt; Robin A Felder; Pedro A Jose
Journal:  Transl Res       Date:  2014-07-25       Impact factor: 7.012

Review 4.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

5.  Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors.

Authors:  Kyu Seok Kim; Ye Ran Yoon; Hyo Jin Lee; Sehyoun Yoon; Sa-Yong Kim; Seung Woo Shin; Juan Ji An; Min-Seon Kim; Se-Young Choi; Woong Sun; Ja-Hyun Baik
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

6.  Associations between dopamine D2 receptor availability and BMI depend on age.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; David H Zald
Journal:  Neuroimage       Date:  2016-05-18       Impact factor: 6.556

7.  Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Panayotis K Thanos; Jean Logan; David Alexoff; Yu-Shin Ding; Christopher Wong; Yeming Ma; Kith Pradhan
Journal:  Neuroimage       Date:  2008-06-13       Impact factor: 6.556

8.  Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.

Authors:  Xiaoliang Jiang; Prasad Konkalmatt; Yu Yang; John Gildea; John E Jones; Santiago Cuevas; Robin A Felder; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

9.  Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure.

Authors:  Yanrong Zhang; Santiago Cuevas; Laureano D Asico; Crisanto Escano; Yu Yang; Annabelle M Pascua; Xiaoyan Wang; John E Jones; David Grandy; Gilbert Eisner; Pedro A Jose; Ines Armando
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

10.  Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.

Authors:  Michael Ezrokhi; Yahong Zhang; Shuqin Luo; Anthony H Cincotta
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.